CLOs on the Move


 
Founded in 2010, Aver initially developed scalable analytics software for large insurance companies. With the advent of the Affordable Care Act, we saw the chance to make real change. So we created an intuitive software platform to build bundled payments and analyze performance that anyone across the healthcare industry can use. Today, we are one of only a handful of companies with software to automate bundled payments, and we are the only one that can implement any bundling methodology whatsoever. We are a collection of creative Midwesterners dedicated to making positive change in the healthcare payment system. We`re a firm ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.aver.io
  • 41 South High Street Suite 1400
    Colombus, OH USA 43215
  • Phone: 877.841.2775

Executives

Name Title Contact Details

Jobs

Chief Financial Officer

Aver Columbus, OH
Aver is seeking an experienced, dynamic, and flexible leader to join our ever-expanding organization. This person will be directly responsible for managing Aver`s operational and financial management, including but not limited to accounting, finance, forecasting, strategic planning, and deal analysis and negotiations. The CFO will work closely with Aver`s CEO ...

Similar Companies

Adarma

Adarma is a UK-based cybersecurity services company that provides consulting, technology, and managed security services to protect organizations against an increasingly complex and harmful threat landscape.

Atria Data Systems

Atria Data Systems is a Santa Clara, CA-based company in the Software and Internet sector.

SaaSPerts

SaaSPerts provides services for professional service firms, enabling them to create an effective online presence for their prospects and clients.

THH Holdings

THH LLC is a company that specializes in starting up and scaling service related businesses. They provide custom software development, technology integration, cloud management and virtual technology solutions.

Encoded Genomics

Harnessing the power of the regulatory genome to create highly selective, next-generation molecular therapies